The relationship between antioxidant enzymes and bladder cancer

Neoplasma

Volumn 52, Issue 4, 2005, Pages 314-317

  Arikan, S ^a   Akcay, T ^a   Konukoglu, D ^a   Obek, C ^a   Kural, A R ^a  

^a NONE

Author keywords

Bladder cancer; Free radicals; Glutathione peroxidase; Glutathione S transferase; Malondialdehyde

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; BLADDER; BLADDER CANCER; CANCER DIAGNOSIS; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; TRANSITIONAL CELL CARCINOMA;

EID: 23044461238     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ATHAR M. Oxidative stress and experimental carcinogenesis. Indian J Exp Biol 2002; 40(6): 656-667.
2. BUEGE JA, AUST SD. Microsomal lipid Peroxidation. Meth Enzymol 1978; 12: 302-310.
3. BUETLER E, DURAN O, KELLY MB. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 51: 882-888.
4. CATOLONA WJ. Urethelial tumors of the urinary tract. In: Wals PC, Retik AB, Stamey TA, Vaughan ED, editors. Campbell's Urology, 6th edition. Pennsylvania, W.B. Saunders, 1992: 1094-1146.
5. CHEESEMAN KH, SLATER. An introduction to free radical. Biochem Br Med Bull 1993; 49: 481-493.
6. CHOI SC, YUN KJ, KIM TH, KIM HJ, PARK SG et al. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett 2003; 195(2): 169-175.
7. COHEN SM, SHIRAI T, STEINECK G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl. 2000; (205): 105-115.
8. CORNELISSEN J, VAN KUILENBURG AB, VOUTE PA, VAN GENNIP AH. MIBG causes oxidative stress and up-regulation of anti-oxidant enzymes in the human neuroblastoma cell line SK-N-BE(2c). Int J Cancer. 1997; 72(3): 486-490.
9. COTTON SC, SHARP L, LITTLE J, BROCKTON N. Glutathione S Transferase polymorphisms and colorectal cancer. Am J Epidemiol 2000; 151(1): 7-32.
10. DIPLOCK AT, RICE, EVANS CA, BURDON RH. Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention? Cancer Res 1994; 54: 1952-1956,
11. DREHER D, JUNOD AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1995; 32: 30-38.
12. FANG YZ, YANG S, WU G. Free radicals, antioxidants, and nutrition. Nutrition 2002; 18(10): 872-879.
13. FRANKEL S, REITMAN S, SONNENWIRTH AC. Gradwohl's Clinical Laboratory Methods and Diagnosis 1974; 1: 403.
14. GUYTON KZ, KENSLER TW. Oxidative mechanisms in carcinogenesis. Brit Med Bull 1993; 49: 523-544.
15. HABDOUS M, SIEST G, HERBETH B, VINCENT-VIRY M, VISVIKIS S. Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies. Ann Biol Clin (Paris). 2004; 62(1): 15-24.
16. HABIG WM, PABST M, JACOBY WB. Glutathione S-transferases: the first enzymatic step in mercopturic acid formation. J Biol Chem 1974; 249: 7130-7134.
17. HALLIWELL B. Free radicals and antioxidants: a personal view. Nutrition Rev 1994; 52: 253-265.
18. JOHANSSON SL, COHEN SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997; 13(5): 291-298.
19. JOHNS LE, HOULSTON RS. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis. Mutagenesis 2000; 15(5): 399-404.
20. KHANZODE SS, KHANZODE SD, DAKHALE GN. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett 2003; 195(1): 27-31.
21. KOROTKINA RN, MATSKEVICH GN, DEVLIKANOVA ASH, VISHNEVSKII AA, KUNITSYN AG, KARELIN AA. Activity of glutathione-metabolizing and antioxidant enzymes in malignant and benign tumors of human lungs. Bull Exp Biol Med 2002; 133(6): 606-608.
22. LAFUENTE A, RODRIGUEZ A, GIBANEL R, LAFUENTE MJ, ALONSO M et al. Limitations in the use of glutathione S-transferase Pl in urine as a marker for bladder cancer. Anticancer Res 1998; 18(5B): 3771-3772.
23. MANJU V, KALAIVANI SAILAJA J, NALINI N. Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. Clin Biochem 2002; 5(8): 621-625.
24. MARUSIN AV, SALYUKOV VB, BRAGINA EY. Antioxidant activity of blood plasma in individuals with neoplasms. Bull Exp Biol Med 2002; 133(5): 481-483.
25. PAGLIA DE, VALENTINE WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
26. POLAT MF, TAYSI S, GUL M, CIKMAN O, YILMAZ I et al. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct 2002; 20(4): 327-331.
27. POPADIUK S, KORZON M, RENKE J, WOZNIAK M. Carbonyl groups content on the basis of protein peroxidation analysis with total antioxidant status in blood of children with cancers. Wiad Lek 1998; 4: 107-112.
28. STEINHOFF C, FRANKE KH, GOLKA K, THIER R, ROMER HC et al. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000; 74(9): 521-526.
29. SUBAPRIYA R, KUMARAGURUPARAN R, RAMACHANDRAN CR, NAGINIS. Oxidant-antioxidant status in patients with oral squamous cell carcinomas at different intraoral sites. Clin Biochem 2002; 35(6): 489-193.
30. TIETZ NW. Methods for the determination of erythrocyte glutathione reductase activity. In: Tietz NW, Pruden EL, Whitley RJ, Bhavagan NV, Caravay WT, editors. Text Book Of Clinical Chemistry. WB Saunders Comp 1986: 949.
31. ZACHARA BA, MARCHALUK WE, MACIAG A, PEPLINSKI J. Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of the lung cancer. Lung 1997; 175: 321-332.